Bayesian Approaches for Confirmatory Trials in Rare Diseases: Opportunities and Challenges

Moreno Ursino and Nigel Stallard
Additional contact information
Moreno Ursino: Inserm, Centre de Recherche des Cordeliers, Sorbonne Université, USPC, Université de Paris, F-75006 Paris, France
Nigel Stallard: Statistics and Epidemiology, Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry CV4 7AL, UK

IJERPH, 2021, vol. 18, issue 3, 1-9

Abstract: The aim of this narrative review is to introduce the reader to Bayesian methods that, in our opinion, appear to be the most important in the context of rare diseases. A disease is defined as rare depending on the prevalence of the affected patients in the considered population, for example, about 1 in 1500 people in U.S.; about 1 in 2500 people in Japan; and fewer than 1 in 2000 people in Europe. There are between 6000 and 8000 rare diseases and the main issue in drug development is linked to the challenge of achieving robust evidence from clinical trials in small populations. A better use of all available information can help the development process and Bayesian statistics can provide a solid framework at the design stage, during the conduct of the trial, and at the analysis stage. The focus of this manuscript is to provide a review of Bayesian methods for sample size computation or reassessment during phase II or phase III trial, for response adaptive randomization and of for meta-analysis in rare disease. Challenges regarding prior distribution choice, computational burden and dissemination are also discussed.

Keywords: Bayesian; rare disease; prior distribution; meta-analysis; sample size (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2021
References: View references in EconPapers View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/18/3/1022/pdf (application/pdf)
https://www.mdpi.com/1660-4601/18/3/1022/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:18:y:2021:i:3:p:1022-:d:486146

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().